Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Regorafenib Tablets

Approval Number

国药准字H20243496

Company湖南明瑞制药股份有限公司

Registration Date

April 17, 2024

Drug Information

Generic Name

瑞戈非尼片

Dosage Form

片剂

Strength

40mg（按 C₂₁H₁₅ClF₄N₄O₃ 计）

Drug Type

化学药品

Registration Date

April 17, 2024

Company Information

Applicant Company

Company Name湖南明瑞制药股份有限公司

Company Address

湖南省长沙市浏阳经济技术开发区府前路221号

Manufacturing Company

Company Name浙江华义制药有限公司

Company Address

浙江省义乌市佛堂镇双峰路15号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

瑞戈非尼片 - NMPA 批准文号 | MedPath